|
|
Presenting Distinguished International Speakers at ASNO Annual Meeting 2024
|
|
|
Discover an extraordinary gathering of esteemed global thought leaders in neuro-oncology at the highly anticipated ASNO Annual Meeting 2024.
|
|
|
 |
Eric Leuthardt - USA
Chief, Division of Neurotechnology Washington University School of Medicine Topic: The Application of LITT in Glioma Treatment
|
|
 |
Hai Yan - Singapore
NeuroPhenomics Agency for Science, Technology and
Research (ASTAR) Topic: Biologic and Therapeutic Roles of
IDH Mutation
|
|
|
|
 |
Hugues Duffau - France
Professor and Chairman of the
Neurosurgery Department Montpellier University Medical Center Topic: Awake Craniotomy for Low Grade Glioma
|
|
 |
Li Wei Zhang - China
Director of Neurosurgery Department and
Vice President Beijing Tiantan Hospital Topic: Brainstem Glioma Immunotherapy Trial
|
|
|
|
 |
Matthias Preusser - Austria
Professor of Medical Oncology and
Head Clinical Division of Oncology Department of Medicine I Medical University of Vienna Topic: New Advances in Treatment of Breast Cancer with Brain Metastases
|
|
 |
Nathalie Albert - Germany
Senior Physician and
Professor for Nuclear Medicine Ludwig Maximilian University of Munich Topic 1: Clinical Use of PET Imaging in Glioblastoma Topic 2: PET Imaging in Patients with
Brain Metastases
|
|
|
|
 |
Rakesh Jalali - India Medical Director and Lead Neuro-Oncology Apollo Proton Cancer Centre, Chennai,
Tamil Nadu Topic: Precision Radiotherapy Approaches for Minimizing Toxicity in Low Grade Gliomas
|
|
 |
Susan Chang - USA
Director, Division of Neuro-Oncology UCSF Brain Tumor Center Topic: Glioblastoma Clinical Trials and
RANO 2.0
|
|
|
View Full Programme |
*We will be featuring our speakers regularly in future mailers.
|
 |
The 19th ASNO Annual Meeting is a must-attend event due to its comprehensive coverage of cutting-edge topics in neuro-oncology. The sessions will delve into crucial topics such as IDH – Mutant Low Grade Glioma, Glioblastoma - IDH Wild Type, providing invaluable insights into tumour surgery, current practices, and future trends over the next 20 years. You'll gain a deep understanding of cutting-edge neuro-oncology practices in Asia, including advancements in radiation oncology, survivorship, nursing care, and the management of brain/spine metastases. Additionally, the conference will cover the importance of multidisciplinary care, pediatric neuro-oncology, and patient advocacy, making it an indispensable learning adventure for anyone in this field.
|
|
|
|
|
|
We are extending the early bird rate deadline to 14 June 2024! Don’t miss this chance to register at a special rate.
|
Register Now |
|
|
|
Connect with us on LinkedIn for more updates on the exciting programme:
|
|
|
|